Skip to main content
Robert Conley, MD, Psychiatry, Annapolis, MD

RobertRussellConleyMDFACNP(He/Him)

Psychiatry • Annapolis, MD

Neuropsychiatry, Pain Medicine, Psychopharmacology

Adjunct Professor, Psychiatry, University of Maryland School of Medicine

Join to view full profile

Dr. Conley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Conley's full profile

Already have an account?

  • Office

    2989 Friends Road
    Annapolis, MD 21401
    Phone+1 410-703-1155

Summary

  • Dr. Robert Conley is a psychiatrist in Annapolis, MD; he is Chief Science Officer at Beckley Psytech and is affiliated with University of Maryland Medical Center. He received his medical degree from University of Maryland School of Medicine and has been in practice 40 years. He specializes in neuropsychiatry, pain medicine, and psychopharmacology.

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationResidency, Psychiatry, 1981 - 1985
  • The Johns Hopkins University
    The Johns Hopkins UniversityBA, Natural Science, Honors, AED, 1977 - 1981
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 1981, MD, Honors, AOA

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1989 - 2024
  • PA State Medical License
    PA State Medical License 1983 - 2008
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Fellow, American College of Neuropsychopharmacology ACNP

Publications & Presentations

PubMed

Press Mentions

  • Mental Health: Superiority of New Schizophrenia Drug Gets Challenged
    Mental Health: Superiority of New Schizophrenia Drug Gets ChallengedFebruary 18th, 2020

Grant Support

  • The Effects Of The Cannabinoid-1 Receptor Antagonist Rimonabant On Weight...National Institute Of Mental Health2006
  • 3 Arm StudyNational Center For Research Resources2004
  • New Antipsychotic Strategies In SchizophreniaNational Institute Of Mental Health1997–2001
  • New Atypical Neuroleptic Strategies In SchizophreniaNational Institute Of Mental Health1993–1996

Industry Relationships

  • Distinguished Scholar, Eli LillyFull time employee2008 - 2021

Dr. Robert Conley, Dr. Robert Conley, MD, Dr. R Conley, Dr. Robert Russell Conley